Skip to Main Content

Paper Details

Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.
Nat Commun
31
2022
Author NameAffiliation
David J McConkeyJohns Hopkins University
  • 1 - 1

Datasets

Release 1.2